Johnson T S, Griffin M, Thomas G L, Skill J, Cox A, Yang B, Nicholas B, Birckbichler P J, Muchaneta-Kubara C, Meguid El Nahas A
Sheffield Kidney Institute, Northern General Hospital NHS Trust, Sheffield S5 7AU, United Kingdom.
J Clin Invest. 1997 Jun 15;99(12):2950-60. doi: 10.1172/JCI119490.
Tissue transglutaminase is a calcium-dependent enzyme that catalyzes the cross-linking of polypeptide chains, including those of extracellular matrix (ECM) proteins, through the formation of epsilon-(gamma-glutamyl) lysine bonds. This crosslinking leads to the formation of protein polymers that are highly resistant to degradation. As a consequence, the enzyme has been implicated in the deposition of ECM protein in fibrotic diseases such as pulmonary fibrosis and atherosclerosis. In this study, we have investigated the involvement of tissue transglutaminase in the development of kidney fibrosis in adult male Wistar rats submitted to subtotal nephrectomy (SNx). Groups of six rats were killed on days 7, 30, 90, and 120 after SNx. As previously described, these rats developed progressive glomerulosclerosis and tubulo-interstitial fibrosis. The tissue level of epsilon-(gamma-glutamyl) lysine cross-link (as determined by exhaustive proteolytic digestion followed by cation exchange chromatography) increased from 3.47+/- 0.94 (mean+/-SEM) in controls to 13.24+/-1.43 nmol/g protein 90 d after SNx, P </= 0.01. Levels of epsilon-(gamma-glutamyl) lysine cross-link correlated well with the renal fibrosis score throughout the 120 observation days (r = 0.78, P </= 0.01). Tissue homogenates showed no significant change in overall transglutaminase activity (14C putrescine incorporation assay) unless adjusted for the loss of viable tubule cells, when an increase from 5.77+/-0.35 to 13.93+/-4.21 U/mg DNA in cytosolic tissue transglutaminase activity was seen. This increase was supported by Western blot analysis, showing a parallel increase in renal tissue transglutaminase content. Immunohistochemistry demonstrated that this large increase in epsilon-(gamma-glutamyl) lysine cross-link and tissue transglutaminase took place predominantly in the cytoplasm of tubular cells, while immunofluorescence also showed low levels of the epsilon-(gamma-glutamyl) lysine cross-link in the extracellular renal interstitial space. The number of cells showing increases in tissue transglutaminase and its cross-link product, epsilon-(gamma-glutamyl) lysine appeared greater than those showing signs of typical apoptosis as determined by in situ end-labeling. This observed association between tissue transglutaminase, epsilon-(gamma-glutamyl) lysine cross-link, and renal tubulointerstitial scarring in rats submitted to SNx suggests that tissue transglutaminase may play an important role in the development of experimental renal fibrosis and the associated loss of tubule integrity.
组织转谷氨酰胺酶是一种钙依赖性酶,它通过形成ε-(γ-谷氨酰基)赖氨酸键催化多肽链的交联,包括细胞外基质(ECM)蛋白的多肽链。这种交联导致形成高度抗降解的蛋白质聚合物。因此,该酶与诸如肺纤维化和动脉粥样硬化等纤维化疾病中ECM蛋白的沉积有关。在本研究中,我们研究了组织转谷氨酰胺酶在接受次全肾切除术(SNx)的成年雄性Wistar大鼠肾纤维化发展过程中的作用。在SNx后第7、30、90和120天处死每组6只大鼠。如先前所述,这些大鼠出现进行性肾小球硬化和肾小管间质纤维化。ε-(γ-谷氨酰基)赖氨酸交联的组织水平(通过彻底的蛋白水解消化后进行阳离子交换色谱法测定)从对照组的3.47±0.94(平均值±标准误)增加到SNx后90天的13.24±1.43 nmol/g蛋白,P≤0.01。在整个120天的观察期内,ε-(γ-谷氨酰基)赖氨酸交联水平与肾纤维化评分密切相关(r = 0.78,P≤0.01)。除非根据存活肾小管细胞的损失进行校正,否则组织匀浆的总体转谷氨酰胺酶活性(14C腐胺掺入试验)无显著变化,此时可见胞质组织转谷氨酰胺酶活性从5.77±0.35增加到13.93±4.21 U/mg DNA。蛋白质印迹分析支持了这种增加,显示肾组织转谷氨酰胺酶含量平行增加。免疫组织化学表明,ε-(γ-谷氨酰基)赖氨酸交联和组织转谷氨酰胺酶的这种大幅增加主要发生在肾小管细胞的细胞质中,而免疫荧光也显示肾细胞外间质空间中ε-(γ-谷氨酰基)赖氨酸交联水平较低。通过原位末端标记确定,显示组织转谷氨酰胺酶及其交联产物ε-(γ-谷氨酰基)赖氨酸增加的细胞数量似乎多于显示典型凋亡迹象的细胞数量。在接受SNx的大鼠中观察到的组织转谷氨酰胺酶、ε-(γ-谷氨酰基)赖氨酸交联与肾小管间质瘢痕形成之间的关联表明,组织转谷氨酰胺酶可能在实验性肾纤维化的发展以及相关的肾小管完整性丧失中起重要作用。